Ir para o conteúdo principal

Australian Clinical Labs (ASX: ACL) — Perfil da empresa, notícias e dados financeiros

Logo de Australian Clinical Labs
ACL Australian Clinical Labs
Australian Clinical Labs primary media
Perfil da empresa

Australian Clinical Labs

Australian Clinical Labs is a private provider of pathology and medical laboratory services based in Australia. The organization operates a nationwide network of laboratory facilities and patient collection centers, serving general practitioners, medical specialists, private and public hospitals, clinical trial sponsors, and commercial corporate clients. Its service portfolio includes routine diagnostic pathology across hematology, biochemistry, and microbiology, alongside specialized offerings in genetic testing, non-invasive prenatal screening, molecular cancer diagnostics, cardiac testing, and occupational health screening. The company also integrates digital health technology tools to deliver electronic pathology requesting and results management to medical practices across Australia.

Resumo

Public AUParticipação acionária
2020Ano de fundação
1,001–5,000Funcionários
Clayton, AustraliaSede
Carregando mapa...
Presença global

Operações

Todos os locais
Australia

Produtos e/ou serviços de Australian Clinical Labs

  • Routine Pathology Testing: Comprehensive diagnostic pathology services encompassing hematology, clinical chemistry, microbiology, and histopathology for general practitioners, medical specialists, and public and private hospital clients across an extensive national network of collection centers and laboratories.
  • Specialised Diagnostic Testing: Advanced diagnostic pathology solutions including antenatal screening, cardiac biomarker evaluation, cervical screening, respiratory pathogen panels, sexually transmitted infection analysis, and comprehensive allergy diagnostic testing for medical practitioners and patient management.
  • Genetic Testing Services: Advanced genomic diagnostic offerings covering non-invasive prenatal testing, genetic carrier screening for inherited disorders, pharmacogenetic analysis for targeted medication selection, and specialized molecular cancer diagnostic testing for oncology patients.
  • Commercial Pathology Services: Tailored occupational health testing solutions comprising workplace drug and alcohol screening, pre-employment health evaluations, employee immunity assessments, biological monitoring, and environmental water testing for industrial and corporate organizations.
  • Clinical Trials Services: Central laboratory and analytical trial support services providing customized diagnostic protocols, specialized specimen handling, trial logistics, and regulatory-compliant testing services for pharmaceutical companies, biotechnology firms, and research institutions.
  • Digital Pathology Integration: Health technology solutions facilitating electronic pathology requesting, automated result distribution, digital courier ordering systems, mobile SMS patient test notifications, and direct electronic medical record software integration for healthcare providers.

equipe executiva do Australian Clinical Labs

  • Gregory John HoranGroup CEO, MD & Executive Director
  • Anthony FriedliChief Operating Officer
  • Sean JacksonChief Information Officer
  • Joe GeranNational Marketing Director
  • Associate Prof. Tony LandgrenNational Medical Director & Chief Pathologist
  • Chris BrownlowChief Executive Officer of New South Wales & Australian Capital Territory
  • Shae SeymourChief Risk Officer & CEO of WA/SA/NT
  • Eleanor PadmanCompany Secretary
  • Darren McKeeChief Executive Officer of Victoria

Comunicados recentes

O que a Australian Clinical Labs (ACL) comunicou ao mercado, do mais recente para o mais antigo.

  1. Ceasing to be a substantial holder
  2. Correction to Notice of Meeting for 2026 AGM
  3. Becoming a substantial holder
  4. Change of Auditor
  5. Appointment of non-executive director - Dr Amandeep Hansra
  6. Update on third party cyber incident impacting SunDoctors

Histórico de dividendos

Dividendos por ação pagos pela Australian Clinical Labs, por ano fiscal.

Dividendos por ação da Australian Clinical Labs por ano fiscal
Ano fiscalIntermediárioFinalEspecialTotal
FY2027(até o momento)A$0.0925——A$0.0925
FY2026A$0.0900A$0.0375—A$0.1275
FY2025A$0.0900A$0.0350—A$0.1250
FY2024A$0.0700A$0.0300—A$0.1000
FY2023A$0.4100A$0.0700—A$0.4800

Principais indicadores financeiros

Resultados divulgados pela Australian Clinical Labs, em AUD.

Cap. de mercado
604,3 mi
Receita (TTM)
736,2 mi
P/L
27.0
LPA (diluído, TTM)
0.1
Dividend yield
4.1%
Margem de lucro
3.2%
Receita e lucro anuais da Australian Clinical Labs
Fim do ano fiscalReceitaResultado operacionalLucro líquido
729,5 mi61,5 mi23,7 mi
741,3 mi270,9 mi32,4 mi
689,7 mi56,9 mi23,9 mi
692,1 mi56,1 mi35,9 mi